1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Prostate Cancer Vaccines - Competitive Intelligence Analysis, November 2019

Prostate Cancer Vaccines - Competitive Intelligence Analysis, November 2019

  • February 2020
  • 94 pages
  • ID: 5843733
  • Format: PDF
  • Delve Insight


Table of Contents

“Prostate Cancer Vaccines - Competitive Intelligence Analysis, 2019” report outlays comprehensive insights of present scenario and growth prospects across Prostate Cancer Vaccines. A detailed picture of the pipeline landscape is provided along with respective companies’ overview with summation of data from multiple sources and complete analysis by development stage, mechanism of action, route of administration and target type.
The report provides a brief introduction on prostate cancer along with few pointers covering epidemiological data, followed by different types of prostate cancer vaccines. A brief topic is also provided on mechanism of action of these prostate cancer vaccines. To make the report more insightful, certain timelines and milestones in cancer vaccines development along with guidelines in 7MM are also covered.
Product information along with company overview covered by Phase
• Phase III, Phase II, Phase I
• Technology based companies

Key Highlights Offered in the Report:
• Cancer treatment vaccines, also called therapeutic vaccines, are a type of immunotherapy. The vaccines work to boost the body’s natural defenses to fight cancer. Doctors give treatment vaccines to people already diagnosed with cancer.
• According to the National Cancer Institute, prostate cancer is one of the most common cancers in men in the U.S., second to skin cancer, and is also the second leading cause of death in men.
• The 2016 annual sales of prostate cancer vaccines was approximately USD 300 million.
• Provenge (sipuleucel-T) is the only prostate cancer vaccine product approved in the market by FDA, however 20+ companies are having their products in different clinical phase of development.
Key Players:
• Dendreon Corporation
• Bavarian Nordic
• Advantagene
• OncBioMune Pharmaceuticals
• Advaxis immunotherapies
• Cleveland BioLabs Inc.
• Curevac AG
• Mediolanum Farmaceutici
• Pfizer Inc.
• Vaccitech
• Sensei Biotherapeutics
• Medigene AG
• Ultimovacs
• Oncovir Inc.
• UbiVac
• Momotaro-Gene Inc.
• Vaccibody AS
• AlphaVax Inc.
Overview of pipeline development activities for Prostate Cancer Vaccines
Pipeline analysis of cancer vaccines include but are not limited to product description, company description and development activities focusing on technology, designations, collaborations & licensing deals, grants, and patent details. In the coming years, products in late stage of development, such as Prostvac (Bavarian Nordic) and ProstAtak (Advantagene) are likely to give tough competition to the products currently available in the market.
Therapeutic segmentation of products for Prostate Cancer Vaccines
The report comprises of comparative pipeline therapeutics assessment by development stage, target, mode of administration, mechanism of action, route of administration across the prostate cancer vaccines. Most drugs in the pipeline are Immuno-stimulants or toll-like receptor agonists.
Key Market Drivers
• Increasing clinical development activities
• Combination with chemotherapy
• Tumor Antigens
• Prostate Cancer Vaccines better than gene-editing therapies

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• Provides an overview of therapeutic pipeline activity for Prostate Cancer Vaccines across the complete product development cycle and company overview.
• It comprises of detailed profiles of Prostate Cancer Vaccines with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations and technologies.
• Therapeutic assessment of the active pipeline products by stage, target, route of administration and mode of administration.
• The report provides a section on patent overview where thorough analysis of the patents with respect to top assignee and top inventors are provided.
• The report also covers market drivers, market barriers and market opportunities and SWOT analysis to build the in depth understanding of prostate cancer vaccines market.

Reasons to Buy
• Establish a comprehensive understanding of the current pipeline scenario across Prostate Cancer Vaccines to formulate effective R&D strategies
• Assess challenges and opportunities that influence Prostate Cancer Vaccines R&D
• Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the products and use it for target finding, drug repurposing, and precision medicine
• Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Prostate Cancer Vaccines to enhance and expand business potential and scope
• Our extensive domain knowledge on therapy areas support the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Prostate Cancer Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

  • $ 5000
  • April 2021
  • 175 pages

Major players in the prostate cancer drugs market are Astellas Inc., AstraZeneca plc, Johnson & Johnson, Sanofi S.A, and Bayer AG. The global prostate cancer drugs market is expected to grow from $3.65 ...

  • World
  • United States
  • Prostate Cancer
  • Industry analysis
  • Drug Approval


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on